Interferon receptor inducer-1

CAS No. 2215120-36-6

Interferon receptor inducer-1( —— )

Catalog No. M23999 CAS No. 2215120-36-6

Interferon receptor inducer-1 Used in the treatment of a disorder in which the induction of interferon is involved. is an interferon (IFN) receptor inducer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 75 In Stock
2MG 42 In Stock
5MG 69 In Stock
10MG 112 In Stock
25MG 225 In Stock
50MG 333 In Stock
100MG 462 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Interferon receptor inducer-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Interferon receptor inducer-1 Used in the treatment of a disorder in which the induction of interferon is involved. is an interferon (IFN) receptor inducer.
  • Description
    Interferon receptor inducer-1 Used in the treatment of a disorder in which the induction of interferon is involved. is an interferon (IFN) receptor inducer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Interferon Receptor
  • Recptor
    interferon inducer
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2215120-36-6
  • Formula Weight
    254.33
  • Molecular Formula
    C12H22N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:55 mg/mL (216.25 mM)
  • SMILES
    CCCC[C@H](CO)NC1=NC(=NC=C1OC)NC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gowan D M , Jonckers T , Raboisson J M . ALKYLPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES:, WO2014023813 A1[P].
molnova catalog
related products
  • CP-28888

    CP-28888 (CP 28888-27) is an interferon inducer, a lipoamine with antitumor activity.

  • IFN-α Receptor Recog...

    IFN-α Receptor Recognition Peptide 1 is a peptide of IFN-α associated with receptor interactions.

  • Anifrolumab

    Anifrolumab(MEDI-546) is a potent type I interferon (IFN) receptor antagonist, a human monoclonal antibody that targets IFN.Anifrolumab inhibits the activity of type I interferon and is used for the prevention and treatment of systemic lupus erythematosus (SLE).